GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.77 $4.97 Friday, 19th Apr 2024 ALDX stock ended at $3.86. This is 3.02% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.28% from a day low at $3.79 to a day high of $3.99.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2021-10-22 $8.10 $8.10 $7.84 $8.03 484 870
2021-10-21 $8.10 $8.23 $8.00 $8.14 529 695
2021-10-20 $8.37 $8.46 $8.08 $8.14 468 387
2021-10-19 $8.34 $8.66 $8.30 $8.41 470 848
2021-10-18 $8.36 $8.46 $8.20 $8.38 592 965
2021-10-15 $8.86 $8.86 $8.30 $8.34 623 386
2021-10-14 $8.69 $8.81 $8.59 $8.71 366 447
2021-10-13 $8.57 $8.67 $8.48 $8.62 395 663
2021-10-12 $8.56 $8.67 $8.48 $8.60 203 423
2021-10-11 $8.41 $8.75 $8.36 $8.56 311 473
2021-10-08 $8.67 $8.68 $8.27 $8.44 361 553
2021-10-07 $8.34 $8.72 $8.21 $8.70 400 114
2021-10-06 $8.91 $9.07 $8.28 $8.33 622 697
2021-10-05 $8.83 $9.40 $8.76 $8.97 855 207
2021-10-04 $8.81 $8.95 $8.69 $8.77 477 233
2021-10-01 $8.87 $9.02 $8.51 $8.87 571 252
2021-09-30 $9.11 $9.11 $8.64 $8.78 943 444
2021-09-29 $8.86 $9.09 $8.81 $8.93 598 015
2021-09-28 $8.68 $8.92 $8.57 $8.81 556 134
2021-09-27 $8.50 $8.94 $8.44 $8.76 749 964
2021-09-24 $8.32 $8.67 $8.32 $8.50 587 869
2021-09-23 $8.14 $8.43 $8.14 $8.40 294 239
2021-09-22 $8.03 $8.29 $7.90 $8.14 535 474
2021-09-21 $8.08 $8.15 $7.90 $7.94 418 956
2021-09-20 $8.37 $8.53 $7.92 $7.99 738 953
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT